Wang Xinghao, Xu Chen, Grzegorzek Marcin, Sun Hongzan
Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China.
Department of Surgical Oncology, The First Affiliated Hospital of China Medical University, Shenyang, China.
Front Physiol. 2022 Aug 25;13:948767. doi: 10.3389/fphys.2022.948767. eCollection 2022.
We aim to develop and validate PET/ CT image-based radiomics to determine the Ki-67 status of high-grade serous ovarian cancer (HGSOC), in which we use the metabolic subregion evolution to improve the prediction ability of the model. At the same time, the stratified effect of the radiomics model on the progression-free survival rate of ovarian cancer patients was illustrated. We retrospectively reviewed 161 patients with HGSOC from April 2013 to January 2019. 18F-FDG PET/ CT images before treatment, pathological reports, and follow-up data were analyzed. A randomized grouping method was used to divide ovarian cancer patients into a training group and validation group. PET/ CT images were fused to extract radiomics features of the whole tumor region and radiomics features based on the Habitat method. The feature is dimensionality reduced, and meaningful features are screened to form a signature for predicting the Ki-67 status of ovarian cancer. Meanwhile, survival analysis was conducted to explore the hierarchical guidance significance of radiomics in the prognosis of patients with ovarian cancer. Compared with texture features extracted from the whole tumor, the texture features generated by the Habitat method can better predict the Ki-67 state ( < 0.001). Radiomics based on Habitat can predict the Ki-67 expression accurately and has the potential to become a new marker instead of Ki-67. At the same time, the Habitat model can better stratify the prognosis ( < 0.05). We found a noninvasive imaging predictor that could guide the stratification of prognosis in ovarian cancer patients, which is related to the expression of Ki-67 in tumor tissues. This method is of great significance for the diagnosis and treatment of ovarian cancer.
我们旨在开发并验证基于PET/CT图像的放射组学方法,以确定高级别浆液性卵巢癌(HGSOC)的Ki-67状态,其中我们利用代谢亚区域演变来提高模型的预测能力。同时,阐述了放射组学模型对卵巢癌患者无进展生存率的分层效应。我们回顾性分析了2013年4月至2019年1月期间的161例HGSOC患者。分析了治疗前的18F-FDG PET/CT图像、病理报告及随访数据。采用随机分组方法将卵巢癌患者分为训练组和验证组。融合PET/CT图像以提取整个肿瘤区域的放射组学特征以及基于栖息地方法的放射组学特征。对特征进行降维处理,并筛选出有意义的特征以形成预测卵巢癌Ki-67状态的特征标签。同时,进行生存分析以探索放射组学在卵巢癌患者预后中的分层指导意义。与从整个肿瘤中提取的纹理特征相比,栖息地方法生成的纹理特征能更好地预测Ki-67状态(<0.001)。基于栖息地的放射组学能够准确预测Ki-67表达,并有潜力成为替代Ki-67的新标志物。同时,栖息地模型能更好地对预后进行分层(<0.05)。我们发现了一种非侵入性成像预测指标,可指导卵巢癌患者预后的分层,这与肿瘤组织中Ki-67的表达相关。该方法对卵巢癌的诊断和治疗具有重要意义。